Gunderson Dettmer has advised Andersen Group Inc. Latham & Watkins has advised the underwriters. Whalen LLP has represented the selling stockholders. Andersen Group Inc. (NYSE: ANDG),...
Andersen Group Secondary Share Offering Raises $188.5 Million
Andersen Group Launches $176 Million Initial Public Offering
Gunderson Dettmer has advised Andersen Group Inc. Cooley LLP has represented the underwriters. Andersen Group Inc. (NYSE: ANDG), a provider of independent tax, valuation, and financial...
Arcus Biosciences Completes $287.5 Million Common Stock Offering
Latham & Watkins has advised Arcus Biosciences. Gunderson Dettmer has advised the underwriters. Arcus Biosciences, a clinical-stage, global biopharmaceutical company listed on the NYSE under the...
Flywire’s $256 Million Common Stock Offering
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian acted as counsel to Flywire, and Goodwin Procter acted as counsel to the underwriters. Flywire Corporation (Nasdaq: FLYW) announced its underwritten...
AltC Acquisition Corp.’s Business Combination with Oklo
Weil, Gotshal & Manges LLP represented AltC Acquisition Corp., while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP represented Oklo Inc. in the transaction. An advanced...
Alimera Sciences’ Acquisition of U.S. Commercial Rights to YUTIQ®
Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc. Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has...